197 related articles for article (PubMed ID: 34670517)
21. [Clinical features and prognosis in 20 children with rhabdomyosarcoma].
Liu SQ; Ye FH; Fan CY; Peng M; Dong JJ; Deng WJ; Zhang H; Yu Y; Yang LC
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Sept 15; 24(9):1036-1041. PubMed ID: 36111723
[TBL] [Abstract][Full Text] [Related]
22. Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M; Stegmaier S; Vokuhl C; Seitz G; von Kalle T; Scheer M; Münter M; Bielack SS; Weclawek-Tompol J; Ladenstein R; Niggli F; Ljungman G; Fuchs J; Hettmer S; Koscielniak E; Klingebiel T;
Pediatr Blood Cancer; 2019 Jun; 66(6):e27652. PubMed ID: 30762282
[TBL] [Abstract][Full Text] [Related]
23. Rhabdomyosarcoma of the female genitourinary tract: Primary and relapsed disease in infants and older children. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Matle M; Vokuhl C; Hallmen E; von Kalle T; Münter M; Timmermann B; Bielack SS; Klingebiel T; Koscielniak E; Seitz G;
Pediatr Blood Cancer; 2021 Apr; 68(4):e28889. PubMed ID: 33438323
[TBL] [Abstract][Full Text] [Related]
24. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas.
Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M
Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794
[TBL] [Abstract][Full Text] [Related]
25. Outcome and prognostic variables in childhood rhabdomyosarcoma (RMS) with emphasis on impact of FOXO1 fusions in non-metastatic RMS: experience from a tertiary cancer centre in India.
Ramanathan S; Sisodiya S; Shetty O; Prasad M; Parambil BC; Shah S; Ramadwar M; Khanna N; Laskar S; Qureshi S; Vora T; Chinnaswamy G
Ecancermedicalscience; 2023; 17():1539. PubMed ID: 37138963
[TBL] [Abstract][Full Text] [Related]
26. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
Rekhi B; Singhvi T
APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
[TBL] [Abstract][Full Text] [Related]
27. Update on molecular findings in rhabdomyosarcoma.
El Demellawy D; McGowan-Jordan J; de Nanassy J; Chernetsova E; Nasr A
Pathology; 2017 Apr; 49(3):238-246. PubMed ID: 28256213
[TBL] [Abstract][Full Text] [Related]
28. Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement.
Krsková L; Mrhalová M; Sumerauer D; Kodet R
Virchows Arch; 2006 Apr; 448(4):449-58. PubMed ID: 16365729
[TBL] [Abstract][Full Text] [Related]
29. Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma.
Krsková L; Mrhalová M; Hilská I; Sumerauer D; Drahokoupilová E; Múdry P; Kodet R
Virchows Arch; 2010 May; 456(5):463-72. PubMed ID: 20405298
[TBL] [Abstract][Full Text] [Related]
30. Clinical Study on Female Genital Tract Rhabdomyosarcoma in Childhood: Changes During 20 Years in One Center.
Yang J; Yang J; Yu M; Yuan Z; Cao D; Keng S
Int J Gynecol Cancer; 2017 Feb; 27(2):311-314. PubMed ID: 27870705
[TBL] [Abstract][Full Text] [Related]
31. Pediatric bladder/prostate rhabdomyosarcoma: Eight cases from a single center.
Emir S; Özdemir Sİ; Demir HA; Özyörük D; Karakuş E; Tiryaki T; Çetindağ F
Turk J Pediatr; 2016; 58(3):254-258. PubMed ID: 28266189
[TBL] [Abstract][Full Text] [Related]
32. Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?
Dantonello TM; Vokuhl C; Scheer M; Sparber-Sauer M; Stegmaier S; Seitz G; Scheithauer H; Faber J; Veit-Friedrich I; Kaatsch P; Bielack SS; Klingebiel T; Koscielniak E;
Virchows Arch; 2018 Mar; 472(3):441-449. PubMed ID: 29468306
[TBL] [Abstract][Full Text] [Related]
33. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W;
Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224
[TBL] [Abstract][Full Text] [Related]
34. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
[TBL] [Abstract][Full Text] [Related]
35. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic characteristics, treatment, prognosis and pregnancy outcomes in rhabdomyosarcoma of the uterine cervix: a case series.
Yu X; Qie M; Huang L; Hou M
Ginekol Pol; 2023 Dec; ():. PubMed ID: 38126889
[TBL] [Abstract][Full Text] [Related]
37. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
38. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J
J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413
[TBL] [Abstract][Full Text] [Related]
39. Outcome of pediatric parameningeal rhabdomyosarcoma. The Children Cancer Hospital, Egypt, experience.
Rahman HA; Sedky M; Mohsen I; Taha H; Loaye I; Zaghloul MS; Wakeel ME; Labib RM
J Egypt Natl Canc Inst; 2013 Jun; 25(2):79-86. PubMed ID: 23719406
[TBL] [Abstract][Full Text] [Related]
40. Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience.
Parasuraman S; Langston J; Rao BN; Poquette CA; Jenkins JJ; Merchant T; Cain A; Pratt CB; Pappo AS
J Pediatr Hematol Oncol; 1999; 21(5):370-7. PubMed ID: 10524449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
